Discovery of Potent 2-Aryl-6,7-dihydro-5 <i>H</i> -pyrrolo[1,2- <i>a</i> ]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design
Feng Wang(Vanderbilt University), Stephen W. Fesik(Vanderbilt University), Qi Sun(Shanxi University), J. Grace Shaw(Vanderbilt University), Jiqing Sai(Vanderbilt University), Olivia W. Rossanese(Vanderbilt University), William P. Tansey(Vanderbilt University), James M. Salovich(Vanderbilt University), Kyu Ok Jeon(Vanderbilt University), Rocco D. Gogliotti(Vanderbilt University), Joannes P. Yuh(Vanderbilt University), DeMarco V. Camper(Vanderbilt University), Shidong Wang(Shaoxing Second Hospital), Joseph Alvarado(Vanderbilt University), Edward T. Olejniczak(Abbott (United States)), Jonathan D. Macdonald(Vanderbilt University), Jason Phan(Vanderbilt University), Shaun R. Stauffer(Cleveland Clinic Lerner College of Medicine)
Cited by 71
Related Papers
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|Cancer Research|2008|2k
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer
|Journal of Medicinal Chemistry|2004|364
Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737
|Cancer Research|2007|302
Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL
|Journal of Medicinal Chemistry|2007|295